Clinical Trial Update: Hydroxyurea Management in Kids: Intensive Versus Stable Dosage Strategies [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intensive versus stable hydroxyurea dosing strategies in children with sickle cell anemia; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Sickle Cell Anemia | Phase 2 | Status: COMPLETED | Results posted: 2021-06-25